The World Health Organization (WHO) on Wednesday announced that it has prequalified new dengue vaccine. According to WHO, the vaccine, developed by Takeda Pharmaceuticals, received ...
, opens new tab dengue vaccine, giving international procurement agencies another option against the disease that affects millions of people each year. The approval, called a prequalification ...
World Health Organization (WHO) has officially prequalified a new vaccine designed to combat the mosquito-borne viral disease ...
A new vaccine for dengue received prequalification from the World Health Organization (WHO) on 10 May 2024. TAK-003 is the second dengue vaccine to be prequalified by WHO. Developed by Takeda, it ...
(MENAFN- Caribbean News Global) GENEVA, Switaerland – A new vaccine for dengue received prequalification from the World Health Organization (WHO) on 10 May 2024. TAK-003 is the second dengue ...
The vaccine, TAK-003, is the second dengue vaccine to be prequalified by WHO. WHO recommends the use of TAK-003 in children aged 6–16 years in settings with high dengue burden and transmission ...
The prequalification of TAK-003 is an important step in the expansion of global access to dengue vaccines, as it is now eligible ...
TAK-003 is the second dengue vaccine to be prequalified by WHO Geneva: The World Health Organization (WHO) said on Wednesday that it had prequalified Takeda Pharmaceuticals' dengue vaccine.